Touro University California Vallejo

University, California, United States

Touro University California Vallejo

University, California, United States
SEARCH FILTERS
Time filter
Source Type

Umpierrez G.E.,Emory University | Bailey T.S.,AMCR Institute Escondido | Carcia D.,Abington Hospital Jefferson Health Abington | Shaefer C.,University of Georgia | And 2 more authors.
Journal of Diabetes | Year: 2017

A large number of patients with type 2 diabetes (T2D) on basal insulin do not reach their HbA1c goals and require additional therapy to address postprandial hyperglycemia. Guidelines from expert bodies have outlined several approaches to accomplish postprandial glucose (PPG) control, and recent literature suggests several more. This article provides strategies for primary care physicians caring for patients with T2D who do not achieve glycemic control with basal insulin alone. Current treatment guidelines and strategies for improving PPG control are reviewed, including the efficacy, safety, and cost-effectiveness of rapid-acting insulin (RAI) analogs, premixed insulin, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), dipeptidyl peptidase 4 inhibitors, sodium-glucose cotransporter 2 inhibitors, and α-glucosidase inhibitors. Other approaches, such as combinations of newer basal insulin plus RAI and a fixed-ratio combination of basal insulin and a GLP-1 RA, are also described. © 2017 John Wiley & Sons Australia, Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine.

Loading Touro University California Vallejo collaborators
Loading Touro University California Vallejo collaborators